Create a picture of how you are feeling on this particular day, said the first exercise in the art therapy. After ten treatments the patients who suffered from severe or moderately severe depression ...

At 36 years old, Cody Harris is starting a new life. Harris has suffered from severe depression, anxiety, obsessive compulsive disorder, and bipolar disorder since he was seven years old. For nearly ...

Moment of Clarity has published a comprehensive new educational resource addressing outpatient treatment for severe depression and the clinical standards that guide care decisions for patients ...

Off-label ketamine is being increasingly used in clinical practice for treatment-resistant depression. Serial infusions of ketamine were no better than midazolam infusions for hospitalized patients ...

Down in the dumps? Help might be hiding in your fridge. A new, first-of-its-kind study suggests a controversial diet could ease severe, drug-resistant depression — with improvements showing up in as ...

BREMERTON -- Kitsap Mental Health Services’ new TMS therapy clinic has provided relief to about two dozen patients experiencing severe depression that cannot be meaningfully treated through ...

CAMBRIDGE, England — Depression affects about one in 20 adults, and while treatments like antidepressants and talk therapy help many people, they fail to work for nearly a third of patients. For these ...

An in-home headset that allows people with depression to send mild electrical current to their brains has been cleared by the Food and Drug Administration, in what medical experts consider a milestone ...

Adding psychotherapy to pharmacologic treatment does not appear to improve treatment outcomes for patients with major depression, new research suggests. Results of a cross-sectional, naturalistic, ...

A single dose of psilocybin coupled with “talk therapy” can significantly reduce depression in people with cancer for up to two years, according to a new study. While the study has limitations, its ...

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral delivery, today announced topline results ...